drugset
Drugs / GSK Biologicals' trivalent influenza vaccine
last change May 2013 re-read 3 minutes ago

GSK Biologicals' trivalent influenza vaccine

also known as LD TIV-AS · TIV

Vaccine

Developed for
influenza

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1 NCT00714285 Comparator Jul 2008 → Jan 2009 influenza GlaxoSmithKline Completed Met primary

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as GSK Biologicals' trivalent influenza vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00714285 ↗
Known as LD TIV-AS “trivalent influenza vaccine (TIV, non-adjuvanted or low-dose adjuvanted [LD TIV-AS])” PMID 23688546 ↗ May 2013
Known as TIV “trivalent influenza vaccine (TIV, non-adjuvanted or low-dose adjuvanted [LD TIV-AS])” PMID 23688546 ↗ May 2013
Modality Vaccine “trivalent influenza vaccine” NCT00714285 ↗
Route Intramuscular “Single intramuscular dose on Day 0.” NCT00714285 ↗